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A B S T R A C T
Cyclophilin D (cypD) modulates the properties of the permeability transition pore, a phenomenon implicated in the man-
ifestation of many diseases including aging. Here, we examined the effects of partial or complete deletion of cypD on i)
lifespan, ii) forebrain protein expression of 18 aging markers as well as regional expression of GFAP, mGluR1, and al-
pha-synuclein, and iii) behaviour of aged (> 24 month) male and female mice. Both male and female cypD heterozygous
but not KO mice exhibited increased lifespans compared to WT littermates, associated with alterations in the protein ex-
pression of some markers, albeit without exhibiting changes in behaviour.
© 2016 Published by Elsevier Ltd.
1. Introduction
Cyclophilin D (cypD) is a mitochondrially localized peptidyl-pro-
lyl cis-trans isomerase (Johnson et al., 1999) and a binding target of
the immunosuppressant cyclosporin A (Davis et al., 2010; Halestrap
and Davidson, 1990). Both physiological and pathological functions
of this protein stem from its isomerase domain (Baines et al., 2005),
modulating the mitochondrial permeability transition pore (PTP)
(Bernardi et al., 2015a). The PTP is a non-selective high-conductance
channel which allows the flux of water and other molecules up to
1500 Da across the inner mitochondrial membrane (Azzolin et al.,
2010). The physiological role of cypD and the PTP is to link mito-
chondrial ATP production with cellular functional demand through
Ca2 + (Korge et al., 2011; Barsukova et al., 2011), reviewed in Elrod
and Molkentin (2013). The contribution of PTP to pathology has
been much more intensely investigated, aided greatly by the avail-
ability of cypD knock-out (KO) mice (Baines et al., 2005; Basso et
al., 2005; Nakagawa et al., 2005; Schinzel et al., 2005). A vast body
of work has led to the understanding that cypD is a critical deter-
minant of a number of pathologies (Bonora et al., 2015), and thus,
a drug target (Waldmeier et al., 2003). Indeed, cypD deficient mice
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overexpressing mutant amyloid precursor protein (mAPP) exhibited
less Ca2 +-induced mitochondrial swelling, increased mitochondrial
Ca2 + uptake capacity, preserved mitochondrial respiratory function
and improved spatial learning/memory, even in old age
(22–24 months of age) (Du et al., 2011). Accordingly, cypD defi-
ciency attenuated mitochondrial and neuronal perturbation in addition
to preserving learning and memory in a mouse model of Alzheimer's
disease (Du et al., 2008), examined at 12 months of age. Furthermore,
the genetic ablation of cypD delayed disease onset, and extended the
lifespan of mutant α-synuclein mice (Martin et al., 2014). Importantly,
not just in the mAPP overexpressing mice (Du et al., 2008) but also
cypD deficiency alone improved spatial learning and memory.
On the other hand, mice lacking cypD exhibited an enhancement
of anxiety, avoidance behaviour was facilitated, and adult-onset obe-
sity was prominently evident from the 10 month of age, which was
not dependent on increased food and/or water intake (Luvisetto et al.,
2008). cypD KO mice also exhibited substantially greater cardiac hy-
pertrophy, fibrosis, and reduction in myocardial function in response
to pressure overload stimulation than WT mice (Elrod et al., 2010).
Along these lines, CaMKIIδc overexpression in cypD KO mice re-
sulted in heart failure characterized by a loss of left ventricular func-
tion and significant mortality (Elrod et al., 2010). Yet, clinical tri-
als have shown that administration of the cyclophilin D inhibitor, cy-
closporin A, was protective to patients immediately after myocardial
http://dx.doi.org/10.1016/j.mito.2017.03.003
1567-7249/© 2016 Published by Elsevier Ltd.
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infarction, when applied during the revascularization phase (Piot et al.,
2008).
Apart from their contribution to the aetiology of diseases, mi-
tochondria have also been considered to be involved in aging
(Crompton, 2004; Toman and Fiskum, 2011). Relevant to this, ag-
ing studies in the human and murine brain resulted in the identifica-
tion of “aging markers” that concern gene expression and DNA dam-
age. Specifically, from post-mortem samples of the frontal pole of 30
individuals ranging in age from 26 to 106, RNA was harvested and
analysed using Affymetrix gene chips (Lu et al., 2004) and age-related
genes were identified by performing statistical group comparison of
frontal cortical samples from individuals ≤ 42 and ≥ 73 years old; it
was found that about 4% of the approximately 11,000 genes analysed
were significantly changed (1.5-fold or more) (Lu et al., 2004). Like-
wise, the effects of aging on gene expression in the brain of mice have
also been examined (Jiang et al., 2001). Statistically significant dif-
ferences in gene expression in the hypothalamus and cortex of young
(2 months old) and aged (22 months old) mice have been found by us-
ing high-density oligonucleotide arrays, and a number of key genes
involved in neuronal structure and signalling were differentially ex-
pressed (Jiang et al., 2001). A similar study using oligonucleotide ar-
rays representing 6347 genes determined the gene-expression profile
of the aging neocortex and cerebellum in mice (Lee et al., 2000).
There, it was found that aging resulted in a gene-expression profile
indicative of an inflammatory response, oxidative stress and reduced
neurotrophic support in both mouse brain regions (Lee et al., 2000).
Mindful of the connection of cypD to PTP and that of the latter
to aging, we examined the contribution of partial or complete dele-
tion of cypD in protein expression of aging markers in the mouse
brain. Given that in the human aging brain, gene expression changes
are sexually dimorphic (Berchtold et al., 2008), we examined both
male and female mice. In the study where human frontal cortex ag-
ing markers were sought (Lu et al., 2004), 466 genes exhibited very
significant alterations. This gene pool was subdivided in 11 “func-
tions”, namely, synaptic functions, vesicular transport, neuronal sur-
vival, protein turnover, amino acid modification, mitochondrial func-
tions, stress response, inflammation, myelination/lipid metabolism,
transcription, and hormonal functions. From these 466 genes, we se-
lected 15 proteins on the basis of four criteria: i) there are well-charac-
terized mouse homologues, ii) they are distributed among most of the
11 subdivided gene pools, iii) they show a large up- or down regula-
tion compared to all members of the 466 genes, and iv) there are veri-
fied antibodies available, which are suitable for both Western blotting
and immunohistochemistry for the expressed proteins in mice. These
proteins were: ATP6V1H, Calbindin, calcineurin B, Cdk5, GFAP,
HIF1α, Leptin Receptor, MEK4, mGluR1, PKC-ɣ, Synapsin, Sortilin
and VAMP1. Additionally, we examined the expression of α-synu-
clein, a marker which is central to disease-progression in Alzheimer's
disease as well as MnSOD as a mitochondrial marker. GAPDH and
β-actin were used as house-keeping genes. Some of the above aging
markers were further selected for quantitative evaluation of immuno-
histochemical sections of the motor cortex, hippocampal and thalamic
regions of the mice. Finally, in addition to examining protein expres-
sion, we also compared the lifespan of the mice groups, and evaluated
their behaviour at > 24 months of age.
2. Results
2.1. The effect of partial or complete deletion of cypD in the lifespan
of male and female mice
As shown in Fig. 1A, the survivals of male WT (n = 514), HT
(n = 147) and KO (n = 644), and in panel 1B female WT (n = 322),
Fig. 1. The effect of partial or complete deletion of cypD in the lifespan of male and fe-
male WT, cypD heterozygous and cypD KO mice. Kaplan-Meier plots were calculated
from lifetime data of WT (green), HT (red) and KO (black) CypD mice. *a < 0.001,
(HT vs WT or KO, either gender) using a post-hoc with a Holm-Sidak test for pairwise
multiple comparison. (For interpretation of the references to color in this figure legend,
the reader is referred to the web version of this article.)
HT (n = 145) and KO (n = 358) were recorded until the time of their
natural death, and plotted using Kaplan-Meier analysis. By applying
a post-hoc with a Holm-Sidak test for pairwise multiple comparisons,
it is apparent that both male and female HT mice exhibited longer
lifespan (p < 0.001) than both WT and KO mice. No statistical sig-
nificant difference was observed between WT and KO mice of either
gender. Some of these mice have undergone behavioural evaluation at
the age of 24 months (see Section 2.4). Interestingly though, male HT
mice exhibited an early lethality compared to KO and WT mice. Gross
pathological examination of the deceased mice did not show any ma-
jor abnormalities, though the exact cause of death was not estimated.
The reason(s) for the early lethality of male HT mice was not investi-
gated further.
2.2. The effect of partial or complete deletion of cypD in the
expression of aging markers in the forebrain of mice
As shown in Fig. 2 for male and Fig. 3 for female, forebrain ho-
mogenates from 5 WT, 5 HT and 5 KO mice (all > 24 months of
age) were probed for the expression of the following proteins: cypD,
β-actin, GAPDH, α-synuclein, ATP6V1H, calbindin, calcineurin B,
Cdk5, GFAP, HIF1α, leptin receptor, MEK4, mGluR1, MnSOD,
PKC-ɣ, synapsin, sortilin and VAMP1. On the left side of the figures,
scanned images of the Western blots are shown. The densitometric
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Fig. 2. Left: Scanned images of Western blotting comparing the forebrain homogenates of 5 WT, 5 cypD heterozygous and 5 cypD KO male mice (all > 24 months of age) on aging
markers, as indicated in the figure. Right: densitometric analysis of the bands from the Western blotting scans. Statistical significance was determined comparing the 3 groups (WT,
HT, KO) by ANOVA on Ranks followed by one-way ANOVA and Tukey's test post-hoc analysis. Data with p < 0.05 were considered significant. Graphs are plotted as means with
bars representing the standard error of the mean. *a < 0.001, WT vs HT; *b, *c = 0.008 WT vs HT, WT vs KO; *d, *e = 0.002 WT vs HT, WT vs KO; *f, *g < 0.001 WT vs HT, WT
vs KO; *h, *i < 0.001 WT vs KO, HT vs KO; *j, *k < 0.001, WT vs KO, HT vs KO; *l, *m < 0.001, WT vs HT, HT vs KO; *n, *o = 0.008 WT vs HT, WT vs KO.
analysis of the bands (assigning an O.D. of 1 for the averaged bands
obtained from the WT mice, black bars) is shown as graphs, plot-
ted as means with bars representing the standard error of the mean,
in the panels to the right. Statistical significance was determined
comparing the 3 groups (WT, HT, KO) by ANOVA on Ranks fol-
lowed by one-way ANOVA and Tukey's test post-hoc analysis. Data
with p < 0.05 were considered significant. All antibodies yielded sin-
gle bands (ex
cept calbindin which yielded a duplet) at the expected molecular
weights. The antibodies used and their titers are shown in Table 1.
Statistical significant differences are indicated in the panels. From the
panel showing the densitometric analysis of the bands corresponding
to cypD, it is evident that HT mice possess 60% (males) and 53% (fe-
males) of the averaged total cypD amount of the WT mice. As ex-
pected, KO mice did not show any cypD immunoreactivity. What is
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Fig. 3. Left: Scanned images of Western blotting comparing the forebrain homogenates of 5 WT, 5 cypD heterozygous and 5 cypD KO female mice (all > 24 months of age) on
aging markers, as indicated in the figure. Right: densitometric analysis of the bands from theWestern blotting scans. Statistical significance was determined comparing the 3 groups
(WT, HT, KO) by ANOVA on Ranks followed by one-way ANOVA and Tukey's test post-hoc analysis. Data with p < 0.05 were considered significant. Graphs are plotted as means
with bars representing the standard error of the mean. *a < 0.001, WT vs HT; *b = 0.01 WT vs HT; *c = 0.023 WT vs KO; *d, e* = 0.003 WT vs HT, WT vs KO; *f = 0.022 WT vs
KO; *g*, *h = 0.02, WT vs KO, HT vs KO.
also evident from the GAPDH blots of the female mice is that there
is very large variability, unlike the blots for β-actin. As elaborated
under the Materials and methods section, by ratioing the densitomet-
ric signal of each band to that obtained using β-actin we obtained
the exact same information regarding statistical comparisons. Thus,
bar-graphs representing densitometric analyses of band intensities are
given by assigning an O.D. of 1 for the averaged bands obtained from
WT mice. From the aging markers, those that yielded statistically
significant differences among the mice groups were: for male mice,
GAPDH, ATP6V1H, cdk5, GFAP, PKC-γ, synapsin and sortilin, and
for female mice, cdk5, GFAP, MEK4, mGluR1 and sortilin. In most
cases the levels were lower either only in KO or both in HT and KO
animals. Only in male KO, PKC-γ and synapsin showed elevations in
protein expression, which were not detected in HT or any other fe
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Table 1
Antibodies used for Western blotting, their titers and origin.
Marker Titer Origin
Alpha synuclein 1:2000 ab78155 (Abcam)
ATP6V1H 1:2000 ab96120 (Abcam)
Beta-actin 1:5000 ab6276 (Abcam)
Calbindin 1:1000 ab11426 (Abcam)
Calcineurin B 1:250 ab94535 (Abcam)
Cdk5 1:2000 ab40773 (Abcam)
CypD 1:1000 MSA04 (Mitosciences)
GAPDH 1:5000 ab8245 (Abcam)
GFAP 1:4000 ab10062 (Abcam)
HIF1 alpha 1:2000 ab1 (Abcam)
Leptin receptor 1:4000 ab5593 (Abcam)
MEK4 1:1000 ab39403 (Abcam)
mGluR1 1:2000 gift from Dr. Shigemoto
MnSOD 1:2000 ab13533 (Abcam)
PKCɣ 1:1000 ab71558 (Abcam)
Sortilin 1:1000 ab16640 (Abcam)
Synapsin II 1:2000 ab76494 (Abcam)
VAMP1 1:1000 ab3346 (Abcam)
male group. A comparison of the changes obtained in our study using
Western blotting and that of Lu et al. (2004) regarding mRNA levels
is shown in Table 2.
2.3. The effect of partial or complete deletion of cypD in the regional
expression of GFAP, mGluR1 and α-synuclein in the brain of mice
As shown in Fig. 4A, the CA1 region of an aged male WT, a
cypD heterozygous and a cypD KO mouse was decorated for mGluR1
(green), GFAP (red), and the neuronal marker NeuN (blue). Similar
stainings were obtained from the brains of female mice (not shown).
In the stratum radiatum, mainly GFAP fibers are visible with reduced
density in HT and KO animals. mGluR1 immuno-positive fibers are
equally present in all three genotypes with more prominent amount
in stratum oriens and alveus. In panel 4B, GFAP-decorated parts of
the motor cortex and thalamus are shown, using single immunocy-
tochemistry by Ni-DAB intensification; this was performed as such
in order to avoid any bleaching of the fluorophores during quan-
tification. Again, for these regions and identical protocols, a similar
staining was obtained from the brains of female mice (not shown).
From these results it is evident that our staining immunohistochem-
ical protocols yielded specific decoration for the intended proteins,
thus affording the necessary assurance for further quantitative evalu-
ation. The results obtained from the quantitative evaluation of GFAP
staining for CA1 region, motor cortex and thalamus are shown
in Fig. 4 panels C–D, E–F, and G–H, for male and female mice, re-
spectively. It is noteworthy, that there seems to be more mGluR1
staining in stratum pyramidale (p) of WT mice, in comparison to HT
and KO mice. We did not seek the reason(s) explaining this finding,
which would warrant the use of electron microscopy in order to iden-
tify precisely the location of the mGLuR1 staining. We speculate that
in WT mice the soma of the neurons or perhaps the perisomatic re-
gion of the neurons (including the soma, proximal dendrites, initial
segments of the axon as well postsynaptic density elements) exhibit
more intense mGLuR1 staining compared to HT or cypD KO mice. It
would be interesting to address the neuronal network changes of glu-
tamatergic innervation of pyramidal neurons among the 3 mice groups
by quantifying the layers of the CA1 region separately using electron
microscopy.
The staining for mGluR1 in the motor cortex and thalamus was
performed using single immunocytochemistry using Ni-DAB intensi-
fication, and a representative IHC micrograph is shown in Fig. 5, for
male mice. Similar stainings were obtained from the brains of female
mice (not shown). The anti-mGluR1 antibody was validated from the
micrographs shown in Figs. 4 and 5, decorating different parts of the
pericarya of dendrites. The results obtained from the quantitative eval-
uation of mGluR1 staining for CA1 region and the motor cortex are
shown in Fig. 5, bottom panels for male and female mice. mGluR1
staining in the thalamus was not quantitated due to the very intense
staining that emerged from this part of the mouse brain.
The staining for α-synuclein in the CA1 region and the following
cortical regions: ‘EC’: entorhinal cortex, ‘S’: subiculum, and ‘Cg2’:
cingulate gyrus subfield 2 was performed using single immunocyto-
chemistry by Ni-DAB intensification, and a representative IHC micro-
graph is shown in Fig. 6, for male mice. Similar stainings were ob-
tained from the brains of female mice (not shown). The expression of
α-synuclein in the thalamus was not investigated, as it has not been
associated with any disease exhibiting a direct relation to aging. The
results obtained from the quantitative evaluation of α-synuclein stain-
ing for CA1 and cortical regions are shown in Fig. 6, bottom panels.
2.4. The effect of partial or complete deletion of cypD on
anxiety-related behaviour
The locomotion-related parameters, namely the number of line
crossings on the OF and the closed arm entries on the EPM (Fig.
7) did not show any significant alterations among genotypes and
genders, suggesting that the anxiety-related parameters are not in-
fluenced by them. However, the anxiety-related measures, the time
Table 2
Comparison of changes in aging markers described in Lu et al. versus this study.
Aging
marker
Fold-change in
study by Lu et al.
Change in this study
WT vs HT (males)
Change in this study
WT vs KO (males)
Change in this study
HT vs KO (males)
Change in this study
WT vs HT (females)
Change in this study
WT vs KO (females)
Change in this study
HT vs KO (females)
α-Synuclein n.d. n.s. n.s. n.s. n.s. n.s. n.s.
ATP6V1H − 2.27 Reduced (p = 0.003) Reduced (p = 0.005) n.s. n.s. n.s. n.s.
Calbindin − 2.50 n.s. n.s. n.s. n.s. n.s. n.s.
Calcineurin − 2.83 n.s. n.s. n.s. n.s. n.s. n.s.
Cdk5 − 3.41 Reduced (p = 0.006) Reduced (< 0.001) n.s. Reduced (p = 0.009) n.s. n.s.
GFAP 1.61 n.s. Reduced (p = 0.002) Reduced (< 0.001) n.s. Reduced (p = 0.019) n.s.
HIF1-α 2.05 n.s. n.s. n.s. n.s. n.s. n.s.
Leptin
receptor
1.69 n.s. n.s. n.s. n.s. n.s. n.s.
MEK4 − 3.09 n.s. n.s. n.s. Reduced (p = 0.006) Reduced (p = 0.009) n.s.
mGluR1 − 2.41 n.s. n.s. n.s. n.s. Reduced (p = 0.022) n.s.
PKC-γ − 1.77 n.s. Increased (p = 0.002) Increased (p < 0.001) n.s. n.s. n.s.
Synapsin − 3.43 n.s. Increased (p = 0.002) Increased (p < 0.001) n.s. n.s. n.s.
Sortilin − 3.52 Reduced (p = 0.008) Reduced (p = 0.045) n.s. n.s. Reduced (p = 0.030) Reduced (p = 0.039)
VAMP1 − 3.42 n.s. n.s. n.s. n.s. n.s. n.s.
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Fig. 4. A: Triple fluorescence immunohistochemistry of mGluR1, GFAP and NeuN expression in the CA1 region of a WT, a cypD heterozygote and a cypD KO aged male mouse.
The individual parts of this hippocampal region are marked in the merged image as ‘r’ for stratum radiatum, ‘p’ for stratum pyramidale, ‘o’ for stratum oriens, and ‘a’ for alveus.
The white bar signifies 50 μm. B: Immunohistochemistry of GFAP expression in motor cortex and thalamus of a WT, a cypD heterozygote and a cypD KO aged male mouse. C-H:
quantification of the number of cells expressing GFAP in the A1 region, motor cortex and thalamus; average of 4 different mice per group, as indicated in the panels. Statistical
significance was determined comparing the 3 groups (WT, HT, KO) by ANOVA on Ranks followed by one-way ANOVA and Tukey's test post-hoc analysis. Data with p < 0.05
were considered significant. Graphs are plotted as means with bars representing the standard error of the mean.*a, *b, *c, *d, *e, *f, *g, *h, *i, *j, *k, *l < 0.001.* b, *d signify WT
vs KO. All other, HT vs KO. (For interpretation of the references to color in this figure, the reader is referred to the web version of this article.)
spent in the centrum of the OF, and the time spend on the open arm of
the EPM was also independent from the genotype and gender.
3. Discussion
Mitochondrial dysfunction is increasingly recognized to be intri-
cately associated with cellular senescence and the overall aging of an
organism, often in ways extending beyond the well-known mecha-
nisms of oxidative stress and bioenergetic deficits (Yin et al., 2016;
Lane et al., 2015; Payne and Chinnery, 2015; Gonzalez-Freire et al.,
2015; Ziegler et al., 2015). More recently, the ‘causality-status’ of
this association has been challenged in light of findings suggesting
that age-dependent mitochondrial dysfunction is not only insufficient
to limit life span, but some of the biochemical manifestations of mi
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Fig. 5. Top panels: Immunohistochemistry of mGluR1 expression in motor cortex and thalamus of a WT, a cypD heterozygote and a cypD KO aged male mouse. Bottom panels:
quantification of the number of particles expressing mGluR1 in the CA1 region and motor cortex; average of 4 different mice per group, as indicated in the panels. Statistical sig-
nificance was determined comparing the 3 groups (WT, HT, KO) by ANOVA on Ranks followed by one-way ANOVA and Tukey's test post-hoc analysis. Data with p < 0.05 were
considered significant. Graphs are plotted as means with bars representing the standard error of the mean. *a, *b < 0.001.
tochondrial stress can even stimulate pro-longevity pathways (Wang
and Hekimi, 2015; Gonzalez-Freire et al., 2015; Yin et al., 2016). In
either case, all studies agree that mitochondrial dysfunction plays a
complex role in regulating cellular and organismal aging.
Mitochondrial dysfunction usually leads to a common final path-
way substantiated by the opening of the PTP (Izzo et al., 2016).
Opening of the PTP has been mostly associated with ominous signs
for the cell, such as inducing necrotic pathways (Bernardi et al.,
2015b). However, cypD-mediated PTP is also associated with phys-
iological events (Laker et al., 2016). Nonetheless, cypD is recog-
nized as a dispensable, but modulatory component of this pore-open-
ing mechanism (Bernardi et al., 2015b; Bonora et al., 2015). In the pre
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Fig. 6. Immunohistochemistry of α-synuclein expression in CA1 region, entorhinal cortex (EC), subiculum (S) and cingulate gyrus subfield 2 (Cg2) of a WT, a cypD heterozygote
and a cypD KO aged male mouse. Bottom panels: quantification of the number of cells expressing α-synuclein in the CA1, EC, S and Cg2 regions; average of 4 different mice per
group, as indicated in the panels. Statistical significance was determined comparing the 3 groups (WT, HT, KO) by ANOVA on Ranks followed by one-way ANOVA and Tukey's
test post-hoc analysis. Data with p < 0.05 were considered significant. Graphs are plotted as means with bars representing the standard error of the mean. *a = 0.002.
sent work we examined the effects of partial or complete deletion
of cypD on i) lifespan, ii) protein expression of aging markers in
whole forebrain as well as regional expression of GFAP, mGluR1 and
α-synuclein and iii) behaviour of aged (> 24 month) male and female
transgenic mice. The rationale of including cypD heterozygous mice
in the study was based on the fact that -to the best of our knowledge-
the overwhelming majority of all other studies using transgenic mice
compared the effects of complete cypD deletion versus WT. How-
ever, Wang et al. (2009) did evaluate the contribution of cypD to hy-
poxic-ischemic injury in WT, HT and KO mice and Eliseev et al.
(2007) the age-dependent level of expression of cypD as a function of
Ca2 +-induced PTP.
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Fig. 7. Behaviour of male and female mice. Left panels: The number of line crossing represents the locomotor activity, and the time spent in centrum is the measure of anxiety-related
behaviour. Right panels: the locomotion on the elevated plus maze is characterized by the number of closed arm entries, while time spent in open arm is the main measure of anxiety.
The open/total entries represent the locomotor-independent anxiety parameters. Data are averages from 10 mice per group.
As noted in Elrod et al. (2010)) Affymetrix gene array analysis
revealed that 362 probe sets were significantly different (ANOVA,
p < 0.01), with a minimum difference in gene expression of 25% be-
tween WT and cypD KO mice. A robust fluctuation in the expres-
sion of many genes is a commonly occurring problem with constitu-
tive transgenic mice which are viable when homozygous. Conditional
or inducible transgenic mice do not suffer from confounding chronic
alterations in the expression of other genes, but such a mouse model
could not have been used for aging studies. Thus, the evaluation of a
moderate decrease in cypD (as in heterozygous mice) is a much better
model for mimicking the effect of a drug inhibiting submaximally its
target. Indeed, as shown in our results, it was the HT mice (both male
and female) that exhibited a longer lifespan, compared to WT and KO
cypD littermates. Relevant to this, treatment of Podospora anserina
(a fungus suitable for aging studies) with low concentrations of cy-
closporin A, also extended lifespan (Brust et al., 2010). As a word of
caution though, male HT mice exhibited an early lethality compared
to KO and WT mice, an observation that was not associated with gross
pathological abnormalities, albeit the exact cause of the death was not
estimated.
To evaluate whether this extension of lifespan is accompanied with
changes in the quality of life in mice, we further examined the pro-
tein expression of aging markers and the behaviour of mice in an
open-field and elevated plus maze test.
Regarding our approach to examine the expression of 15 (plus
β-actin and GAPDH) proteins by Western blotting, instead of evaluat-
ing thousands of genes using RNA-quantitating methods as performed
in Lu et al. (2004), Jiang et al. (2001) and Lee et al. (2000), or per-
haps using even more recently advanced technologies such RNA-Seq
V2 (Bottomly et al., 2011), it cannot be overemphasized
that changes in mRNA do not necessarily reflect changes in protein
expression (Tian et al., 2004; Vogel et al., 2010; Lundberg et al., 2010;
Schwanhausser et al., 2011). A novel methodology that quantitates the
abundance of hundreds if not thousands of different proteins in bio-
logical samples termed Reverse Phase Protein Array (RPPA) is be-
coming increasingly popular (Gallagher and Espina, 2014), however
it still requires the extensive validation of the antibodies used. In our
case, not more than four antibodies have been verified to be suitable
for RPPA protocols (i.e., that of the RPPA Core facility of the MD An-
derson Cancer Center) for the intended proteins. Finally, we have used
immunohistochemical techniques to quantitate the regional expression
of selected aging markers (GFAP, mGluR1 and α-synuclein) in hip-
pocampal, cortical and thalamic regions of the mouse brain, yield-
ing information that are otherwise lost by homogenization procedures
commonly employed prior to Western blotting. The results on pro-
tein expression of aging markers in the mouse forebrain as a func-
tion of gender and cypD and how do these compare to the study of
Lu et al. (2004) regarding mRNA levels are shown in Table 2. Eight
out of the 15 examined aging markers exhibited a statistically sig-
nificant difference among some mice groups. This strongly attests to
the notion that cypD regulates the expression of aging markers in the
murine brain. Nevertheless, for the remaining of comparisons, the par-
tial or complete deletion of cypD was not associated with abolition
of the change of the aging marker as defined by Lu et al. (2004).
For example, in Lu et al. there was an ~ 2 fold change in the to-
tal RNA coding for calbindin, calcineurin, HIF1-α and leptin recep-
tor, while in our study there were no changes in the expression of
these proteins for any comparisons. This reflects at least two facts: i)
in Lu et al., comparisons were made in samples from human brain,
while we compared those from transgenic mice, and ii) Lu et al. ex
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amined total RNA levels, which does not necessarily translate to a dif-
ference in protein expression. By evaluating further the regional pro-
tein expression of GFAP, mGluR1 and α-synuclein in the cortical, hip-
pocampal and thalamic regions, it is striking that the partial disruption
of the cypD gene led to upregulation of GFAP, while the complete
disruption of cypD led to a decrease in GFAP expression. However,
it is must be emphasized that GFAP - and the ‘astrocytic response’ in
general- has been a recurrent theme of investigation regarding aging
and associated maladies throughout the past two decades (Laping et
al., 1994; Baba et al., 1997; Finch, 2003; Middeldorp and Hol, 2011;
Chisholm and Sohrabji, 2016).
The results obtained from the elevated plus maze and the
open-field test revealed no statistically significant differences among
any groups. Although this may be at odds with the results in males
shown in Luvisetto et al. (2008), there the mice were not as aged as
in the present study. Thus, we can conclude that in aged mice the
anxiogenic role of cypD deletion disappeared. Relevant to this, previ-
ous studies showed that aging might influence anxiety behaviour mea-
sured in open-field and elevated plus maze test (Botton et al., 2016;
Shoji et al., 2016). There, it was shown that aging attenuated anxiety
in the elevated plus maze, test but also induced hypolocomotion and
anxiety in open-field.
3.1. Conclusions
The most important finding of the present study is that heterozy-
gous mice exhibited longer lifespan than both cypD KO and WT mice.
This suggests that regarding lifespan, a chronic, mild inhibition of cy-
clophilin D may be more beneficial than its complete absence. On
the other hand, it is important to consider the findings by the group
of Molkentin, where cypD-deficient mice developed pre-existing car-
diac conditions, being more prone to metabolic heart failure (Elrod et
al., 2010); in heart failure patients, this would translate to a probable
inapplicability of chronic use of a cyclophilin D inhibitor. Thus, in
subjects with compromised heart functions, the potential benefits of a
chronic-mild inhibition of cypD on longevity could be outweighed by
an increased risk of aggravating a looming or co-existing cardiac dis-
ease.
It is noteworthy, that there was an early mortality observed only in
HT male mice. We have not sought the reasons for this phenomenon,
which was statistically significant. Perhaps it is also associated with
the increased longevity of the remaining mice, implying that those that
could survive the diminished expression of cypD during their early
life, acquire lifespan-increasing mechanisms, a scheme that operates
only in males.
Finally, the amount of cypD expression appears to exert a com-
plex effect on the expression of other proteins in the brains of aged
male and female mice. Despite the fact that, a ‘clear-cut’ picture did
not emerge from the findings presented above that could allow for
a generalized conclusion, it is interesting that there were gender-de-
pendent alterations: for only male mice, GAPDH, ATP6V1H, PKC-γ
and synapsin, while for only female mice, MEK4 and mGluR1 were
altered. Only for cdk5, GFAP and sortilin changes were observed in
mice of either gender. In most cases the levels were lower either only
in KO or both in HT and KO animals. Only in male KO, PKC-γ and
synapsin showed elevations in protein expression, which were not de-
tected in HT or any other female group. By investigating the regional
expression differences of GFAP, mGluR1 and α-synuclein, we also
report that the partial expression of cypD upregulates GFAP, as op-
posed to downregulation of GFAP if cypD is not expressed, in aged
mice. The biological relevance of cypD-induced alterations in GFAP,
mGluR1 and α-synuclein expression may lie in glial response or as-
trogliosis and synaptic transmission, concepts that are inherently in
volved in cognitive functions as well as pathophysiologic homeostasis
of the brain.
4. Materials and methods
4.1. Animals
Genetically modified mice originating from the C57Bl6/J strain,
which were heterozygous for the gene encoding cypD were obtained
from the Dana-Faber Cancer Institute and mated with C57Bl6/F mice
in our facilities. To ensure a homologous genetic background, the re-
sulting mice were backcrossed with C57Bl6/J mice for at least eight
generations. Mice were housed in a room maintained at 20–22 °C on
a 12-hour light–dark cycle with food and water available ad libitum.
All experimental procedures were performed according to the Animal
Care and Use Committee (Egyetemi Állatkísérleti Bizottság) guide-
lines and the regulations set by the European Communities Council
Directive (2010/63/EU). Mice were categorized in the following six
groups (all aged > 24 months): males, wild-type (WT); males, cypD
+/− (HT); males cypD −/− (KO); females, WT; females, (HT); and fe-
males, (KO).
4.2. Tissue preparation
4.2.1. Tissue preparation for Western blotting
Mice were killed by cervical dislocation. Subsequently, the fore-
brain was carefully taken out as a whole, chopped with scissors and
washed several times with PBS. Then, brain fragments were homoge-
nized in a PBS solution containing 20 mM lauryl-maltoside and a pro-
tease inhibitor cocktail (Calbiochem, Protease Inhibitor Cocktail Set
IV, product number 539136). The processes of brain harvesting and
homogenization took place at 4 °C. Afterwards, the samples were kept
on ice for 30 min; subsequently, they were centrifuged at 3000 rpm for
3 min, and the supernatants were collected, snap-frozen and stored at
− 20 °C till further use.
4.2.2. Tissue preparation for immunohistochemistry
Animals were anesthetized with chloral hydrate (Reanal Private
Ltd., Budapest, Hungary) and transcardially perfused with 4%
paraformaldehyde (Merck, Darmstadt, Germany) containing 2.5%
acrolein (Merck) in 100 mM KH2PO4, pH 6.8. Whole brains were re-
moved from the skulls and post-fixed in 4% paraformaldehyde for
24 h. Coronal blocks were cut so that they contained the entire hip-
pocampi of both hemispheres (between Bregma − 0.82 mm and
− 3.80 mm); the blocks were subsequently immersed into 30% su-
crose. Once the blocks sunk to the bottom of the containers, they were
further cut on a sliding microtome. The coronal sections were cut at a
30 μm thickness and collected one-by-one in 96 well plates. The sec-
tions were kept in a cryoprotectant antifreeze solution (Watson et al.,
1986) at − 20 °C until further use.
4.3. Immunohistochemistry
For single immunocytochemistry of the free floating sections, the
antigen-antibody complex was visualized by conventional Nickel in-
tensified DAB reaction product as described previously (Vereczki et
al., 2006). For fluorescence single, double and triple immunocyto-
chemistry the sections were processed by ABC (ABC Elite Kits, Vec-
tor Laboratories, Burlingame, CA) and biotin amplification as de-
scribed previously (Berghorn et al., 1994). The antibodies used were
as follows: rabbit anti-mGluR1a (a generous gift of Dr. Shigemoto),
dilution for Ni-DAB at 1:30,000, and for biotin amplification fluo-
rescence staining at 1:15,000; mouse anti-GFAP antibody at 1:50,000
(Abcam, Cambridge, UK); mouse anti-NeuN (Chemicon Interna
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tional, Temecula, CA) at 1:7000 for fluorescence staining; mouse
anti-GFAP-Cy3 conjugated antibody (Sigma-Aldrich) at 1:50,000 and
anti-α synuclein at 1:50,000 (Abcam).
4.4. Quantification of immunohistochemical results
The sections were evaluated by using quantitative sampling ap-
proach with a random starting point; 5 sections from the brain of
each animal were selected that were equally distant from each other.
For GFAP, cells were counted, and for mGLuR1 and α-synuclein,
particles were counted. Counting occurred using ImageJ. Regarding
mGLuR1 and α-synuclein, by using a tool of the ImageJ software we
could set the size of the particles to be counted; thus we used iden-
tical sets for each section from the different groups (WT, HT, KO)
in order to avoid a subjective bias and perform un-biased statistical
comparisons. For GFAP, by using ImageJ we counted the number of
GFAP-positive stained cells in each section. Statistical significance
was determined comparing the 3 groups (WT, HT, KO) by ANOVA
on Ranks followed by one-way ANOVA and Tukey's test post-hoc
analysis. Data with p < 0.05 were considered significant.
4.5. Western blotting
Frozen pellets were thawed on ice, their protein concentration
was determined using the bicinchoninic acid assay and separated by
sodium dodecyl sulfate – polyacrylamide gel electrophoresis
(SDS-PAGE). Separated proteins were transferred to a methanol-acti-
vated polyvinylidene difluoride membrane. Immunoblotting was per-
formed as recommended by the manufacturers of the antibodies. The
antibodies used and their titers are shown in Table 1. Immunoreac-
tivity was detected using the appropriate peroxidase-linked secondary
antibody (1:5000, donkey anti-rabbit or donkey anti-mouse, Jackson
Immunochemicals Europe Ltd., Cambridgeshire, UK) and enhanced
chemiluminescence detection reagent (ECL system; Amersham Bio-
sciences GE Healthcare Europe GmbH, Vienna, Austria). Densito-
metric analysis of the bands was performed in Fiji (Schindelin et al.,
2012). We have also ratioed the densitometric signal of each band to
that obtained using β-actin (for the corresponding mouse brain sam-
ple), however, this has yielded the exact same information regarding
statistical comparisons; this is probably due to the lack of variability of
β-actin expression among mice and genotypes. Thus, bar-graphs rep-
resenting densitometric analyses of band intensities are given by as-
signing an O.D. of 1 for the averaged bands obtained from WT mice.
4.6. Behavioural tests
The tests were videotaped and analysed later by an experimenter
blind to the treatments by means of a computer-based event recorder
(H77, Budapest, Hungary). Behavioural parameters are expressed as
average ± SEM for all groups; data were analysed by using two-way
ANOVA (factors: gender and genotypes). As there was no interaction
between the main factors, post hoc analysis was not conducted.
4.6.1. Open field test
The open field (OF) was a white non-transparent plastic box of
45 × 45 × 25 cm (height). Subjects were placed in one corner of the
OF and were allowed to explore it for 5 min. The apparatus was cov-
ered with a transparent Plexiglas lid during testing and was cleaned
with tap water and a paper towel between subjects. Locomotor activ-
ity was scored by counting the crossings of the lines that divided the
open field into 16 equal squares. The grid was drawn on the video
screen; thus, it was invisible to the subjects. Exploration in the central
area (i.e. the 4 squares in the center of the apparatus) was also scored
as a measure of anxiety-like behaviour.
4.6.2. Elevated plus maze
The Elevated plus maze (EPM) was made of black-painted alu-
minium. It consisted of two open arms (30 × 7 cm) and two closed
arms (30 × 7 cm with 30 cm high walls) that were connected by a cen-
tral platform (7 × 7 cm). The plus maze was elevated to 70 cm from
the floor. Each mouse was transferred in the home-cage from the hous-
ing room to the test room and was immediately placed on the cen-
tral platform of the EPM, with the head facing one of the open arms.
The apparatus was cleaned with tap water and a paper towel between
tests. EPM exposure lasted 5 min. The percentage of time spent in
open arms and open/total (open plus closed) arm entries ratio (an entry
was defined as having three paws of animal in a defined compartment)
were calculated and used as measures of anxiety-like behaviour. The
number of closed arm entries was used to estimate the general loco-
motor activity of the animal.
4.7. Statistics
For behavioural parameters average ± SEM were given for all
groups and the data were analysed by using two-way ANOVA (fac-
tors: gender and genotypes). As there was no interaction between the
main factors, post hoc analysis was not conducted. For Western blot-
ting and IHC, mean sample value and standard deviation was cal-
culated using the 5 samples of each group, and 4 samples for IHC
slide, respectively. Western blotting experiments were done in dupli-
cates if there were no differences among mice groups, or triplicates,
if there were differences observed. Statistical significance was deter-
mined comparing the 3 groups (WT, HT, KO) by ANOVA on Ranks
followed by one-way ANOVA and Tukey's test post-hoc analysis.
Data with p < 0.05 were considered significant. Graphs are plotted as
means with bars representing the standard error of the groups. Sur-
vival rates were analysed using a Kaplan-Meier survival analysis and
post-hoc with a Holm-Sidak test for pairwise multiple comparison.
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